É um câncer que afeta o ovário, podendo ter começado nele (primário) ou se espalhado de outro lugar (metastático). A maioria dos cânceres primários de ovário são carcinomas (tipos comuns incluem o seroso, mucinoso ou endometrióide) ou tumores malignos de células germinativas (que se originam das células que formam os óvulos). Já os cânceres que se espalham para o ovário (metastáticos) podem ser carcinomas, linfomas (câncer do sistema linfático) e melanomas (um tipo de câncer de pele).
Introdução
O que você precisa saber de cara
É um câncer que afeta o ovário, podendo ter começado nele (primário) ou se espalhado de outro lugar (metastático). A maioria dos cânceres primários de ovário são carcinomas (tipos comuns incluem o seroso, mucinoso ou endometrióide) ou tumores malignos de células germinativas (que se originam das células que formam os óvulos). Já os cânceres que se espalham para o ovário (metastáticos) podem ser carcinomas, linfomas (câncer do sistema linfático) e melanomas (um tipo de câncer de pele).
Tem tratamento?
Escala de raridade
<1/50kMuito rara
1/20kRara
1/10kPouco freq.
1/5kIncomum
1/2k
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Entender a doença
Do básico ao detalhe, leia no seu ritmo
Preparando trilha educativa...
Sinais e sintomas
O que aparece no corpo e com que frequência cada sintoma acontece
Partes do corpo afetadas
+ 11 sintomas em outras categorias
Características mais comuns
Os sintomas variam de pessoa para pessoa. Abaixo estão as 18 características clínicas mais associadas, ordenadas por frequência.
Linha do tempo da pesquisa
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Genética e causas
O que está alterado no DNA e como passa nas famílias
Genes associados
12 genes identificados com associação a esta condição.
Key downstream component of the canonical Wnt signaling pathway (PubMed:17524503, PubMed:18077326, PubMed:18086858, PubMed:18957423, PubMed:21262353, PubMed:22155184, PubMed:22647378, PubMed:22699938). In the absence of Wnt, forms a complex with AXIN1, AXIN2, APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its subsequent degradation by the proteasome (PubMed:17524503, PubMed:18077326, PubMed:18086858, PubMed:189574
CytoplasmNucleusCytoplasm, cytoskeletonCell junction, adherens junctionCell junctionCell membraneCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, spindle poleSynapseCytoplasm, cytoskeleton, cilium basal body
Colorectal cancer
A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history.
Binds opioids in the presence of acidic lipids; probably involved in cell contact
Cell membrane
Ovarian cancer
The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease.
Inhibins/activins are involved in regulating a number of diverse functions such as hypothalamic and pituitary hormone secretion, gonadal hormone secretion, germ cell development and maturation, erythroid differentiation, insulin secretion, nerve cell survival, embryonic axial development or bone growth, depending on their subunit composition Activin A is a homodimer of INHBA that plays a role in several essential biological processes including embryonic development, stem cell maintenance and dif
Secreted
Transcriptional regulator. Critical factor essential for ovary differentiation and maintenance, and repression of the genetic program for somatic testis determination. Prevents trans-differentiation of ovary to testis through transcriptional repression of the Sertoli cell-promoting gene SOX9 (By similarity). Has apoptotic activity in ovarian cells. Suppresses ESR1-mediated transcription of PTGS2/COX2 stimulated by tamoxifen (By similarity). Is a regulator of CYP19 expression (By similarity). Par
Nucleus
Blepharophimosis, ptosis, and epicanthus inversus syndrome
A disorder characterized by eyelid dysplasia, small palpebral fissures, drooping eyelids and a skin fold curving in the mediolateral direction, inferior to the inner canthus. In type I BPSE (BPES1) eyelid abnormalities are associated with female infertility. Affected females show an ovarian deficit due to primary amenorrhea or to premature ovarian failure (POF). In type II BPSE (BPES2) affected individuals show only the eyelid defects.
Functions within a multiprotein E3 ubiquitin ligase complex, catalyzing the covalent attachment of ubiquitin moieties onto substrate proteins (PubMed:10888878, PubMed:10973942, PubMed:11431533, PubMed:12150907, PubMed:12628165, PubMed:15105460, PubMed:16135753, PubMed:21376232, PubMed:21532592, PubMed:22396657, PubMed:23620051, PubMed:23754282, PubMed:24660806, PubMed:24751536, PubMed:29311685, PubMed:32047033). Substrates include SYT11 and VDAC1 (PubMed:29311685, PubMed:32047033). Other substra
Cytoplasm, cytosolNucleusEndoplasmic reticulumMitochondrionMitochondrion outer membraneCell projection, neuron projectionPostsynaptic densityPresynapse
Parkinson disease
A complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability. Additional features are characteristic postural abnormalities, dysautonomia, dystonic cramps, and dementia. The pathology of Parkinson disease involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain. The disease is progressive and usually manifests after the age of 50 years, although early-onset cases (before 50 years) are known. The majority of the cases are sporadic suggesting a multifactorial etiology based on environmental and genetic factors. However, some patients present with a positive family history for the disease. Familial forms of the disease usually begin at earlier ages and are associated with atypical clinical features.
Phosphoinositide-3-kinase (PI3K) phosphorylates phosphatidylinositol (PI) and its phosphorylated derivatives at position 3 of the inositol ring to produce 3-phosphoinositides (PubMed:15135396, PubMed:23936502, PubMed:28676499). Uses ATP and PtdIns(4,5)P2 (phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3) (PubMed:15135396, PubMed:28676499). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1,
AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMe
CytoplasmNucleusCell membraneMitochondrion intermembrane space
Breast cancer
A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case.
Cadherins are calcium-dependent cell adhesion proteins (PubMed:11976333). They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. CDH1 is involved in mechanisms regulating cell-cell adhesions, mobility and proliferation of epithelial cells (PubMed:11976333). Promotes organization of radial actin fiber structure and cellular response to contractile forces, via its interaction with AMOTL2 whi
Cell junction, adherens junctionCell membraneEndosomeGolgi apparatus, trans-Golgi networkCytoplasmCell junction, desmosome
Diffuse gastric and lobular breast cancer syndrome
A cancer predisposition syndrome with increased susceptibility to diffuse gastric cancer. Diffuse gastric cancer is a malignant disease characterized by poorly differentiated infiltrating lesions resulting in thickening of the stomach. Malignant tumors start in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. In addition to gastric cancer, most female mutation carriers develop lobular carcinoma of the breast.
May be involved in follicular development. Oocyte-specific growth/differentiation factor that stimulates folliculogenesis and granulosa cell (GC) growth
Secreted
Ovarian dysgenesis 2
A disorder characterized by lack of spontaneous pubertal development, primary amenorrhea, uterine hypoplasia, and hypergonadotropic hypogonadism as a result of streak gonads.
Double-stranded RNA (dsRNA) endoribonuclease playing a central role in short dsRNA-mediated post-transcriptional gene silencing. Cleaves naturally occurring long dsRNAs and short hairpin pre-microRNAs (miRNA) into fragments of twenty-one to twenty-three nucleotides with 3' overhang of two nucleotides, producing respectively short interfering RNAs (siRNA) and mature microRNAs. SiRNAs and miRNAs serve as guide to direct the RNA-induced silencing complex (RISC) to complementary RNAs to degrade them
CytoplasmCytoplasm, perinuclear region
Pleuropulmonary blastoma
A rare pediatric intrathoracic neoplasm. The tumor arises from the lung, pleura, or both, and appears to be purely mesenchymal in phenotype. It lacks malignant epithelial elements, a feature that distinguishes it from the classic adult-type pulmonary blastoma. It arises during fetal lung development and is often part of an inherited cancer syndrome. The tumor contain both epithelial and mesenchymal cells. Early in tumorigenesis, cysts form in lung airspaces, and these cysts are lined with benign-appearing epithelium. Mesenchymal cells susceptible to malignant transformation reside within the cyst walls and form a dense layer beneath the epithelial lining. In a subset of patients, overgrowth of the mesenchymal cells produces a sarcoma, a transition that is associated with a poorer prognosis. Some patients have multilocular cystic nephroma, a benign kidney tumor.
Protein tyrosine kinase that is part of several cell surface receptor complexes, but that apparently needs a coreceptor for ligand binding. Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Regulates outgrowth and stabilization of peripheral microtubules (MTs). Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell memb
Cell membraneCell projection, ruffle membraneEarly endosomeCytoplasm, perinuclear regionNucleusCytoplasm
Glioma
Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes.
ATPase involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner (PubMed:15075294, PubMed:29374058, PubMed:30339381, PubMed:32459350). Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter ac
Nucleus
Rhabdoid tumor predisposition syndrome 2
A familial cancer syndrome predisposing to renal or extrarenal malignant rhabdoid tumors and to a variety of tumors of the central nervous system, including choroid plexus carcinoma, medulloblastoma, and central primitive neuroectodermal tumors. Rhabdoid tumors are the most aggressive and lethal malignancies occurring in early childhood.
Medicamentos e terapias
Mecanismo: DNA polymerase (alpha/delta/epsilon) inhibitor
Mecanismo: DNA topoisomerase II alpha inhibitor
Mecanismo: PARP 1, 2 and 3 inhibitor
Mecanismo: Poly [ADP-ribose] polymerase 2 inhibitor
Mecanismo: PARP 1, 2 and 3 inhibitor
Mecanismo: Vascular endothelial growth factor A inhibitor
Variantes genéticas (ClinVar)
2,114 variantes patogênicas registradas no ClinVar.
Vias biológicas (Reactome)
154 vias biológicas associadas aos genes desta condição.
Diagnóstico
Os sinais que médicos procuram e os exames que confirmam
Tratamento e manejo
Remédios, cuidados de apoio e o que precisa acompanhar
Onde tratar no SUS
Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)
🇧🇷 Atendimento SUS — Câncer de ovário raro
Selecione um estado ou use sua localização para ver resultados.
Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.
Pesquisa ativa
Ensaios clínicos abertos e novidades científicas recentes
Pesquisa e ensaios clínicos
Nenhum ensaio clínico registrado para esta condição.
Publicações mais relevantes
Endometrial pathology and surgical extent in ovarian adult granulosa cell tumor: associations with stage and survival.
Este estudo revelou que a presença de sangramento uterino anormal ou patologias endometriais (hiperplasia ou câncer) está associada a um estágio mais baixo do tumor de células da granulosa (TCG) ovariano, sugerindo uma detecção mais precoce que não afeta negativamente a sobrevida geral das pacientes. Para médicos e pacientes, o estadiamento cirúrgico completo não demonstrou melhorar a sobrevida livre de progressão, embora estágios mais avançados (IC ou superior) continuem associados a um maior risco de recorrência.
🇧🇷 traduzidoSuper-enhancers and efficacy of triptolide in small cell carcinoma of the ovary hypercalcemic type.
O carcinoma de pequenas células do ovário, tipo hipercalcêmico (SCCOHT), é um câncer raro e agressivo que afeta mulheres jovens. Este estudo aprofunda a compreensão de sua biologia, mostrando que a perda de proteínas SMARCA4/SMARCA2 altera "super-enhancers" que regulam genes de desenvolvimento, como os do sistema nervoso. Crucialmente, a pesquisa demonstrou que o composto triptolida (e seu pró-fármaco minnelide) é altamente eficaz contra células de SCCOHT e inibe o crescimento tumoral em modelos pré-clínicos, oferecendo uma promissora nova abordagem terapêutica ao atuar sobre esses "super-enhancers".
🇧🇷 traduzidoExperiences of radiotherapy for treatment of Granulosa Cell Tumor of the ovary: insights from the GCT-survivor sisters.
O tratamento ideal para o Tumor de Células da Granulosa (TCG) ainda é incerto, e a radioterapia, embora não seja comum, é utilizada para a doença recorrente, com sua aplicação variando significativamente entre diferentes países. A maioria das pacientes que receberam radioterapia relata experiências positivas, como eficácia no tratamento e melhoria na qualidade de vida, apesar de algumas terem sofrido efeitos colaterais severos. Isso ressalta a importância de mais pesquisas para estabelecer diretrizes claras sobre o momento e a forma mais eficaz de usar a radioterapia no manejo do TCG.
🇧🇷 traduzidoMultiplexed Imaging Mass Cytometry Reveals Tumor-immune Microenvironment-dependent Hormone Receptor Expression in Adult-Type Ovarian Granulosa Cell Tumors.
Este estudo inovador sobre os raros tumores de células da granulosa do ovário (AGCT), com poucas opções de tratamento para casos recorrentes, revelou a existência de dois subtipos distintos: AGCT-1 e AGCT-2. Esses subtipos diferem significativamente em sua composição celular, atividade imune (com mais macrófagos em tumores recorrentes) e sinais hormonais, como a expressão do receptor de progesterona. Essa nova classificação é crucial para guiar abordagens terapêuticas mais personalizadas e eficazes, oferecendo novas esperanças para pacientes com esta malignidade rara.
🇧🇷 traduzidoThe role of neoadjuvant chemotherapy in advanced-stage clear cell ovarian cancer: A GCIG multi-institutional retrospective cohort study.
Este estudo sobre o câncer de ovário de células claras avançado (OCCC) revela um prognóstico desfavorável, com a quimioterapia neoadjuvante (NACT) não apresentando melhorias significativas na ressecabilidade ou sobrevida em comparação com a cirurgia citorredutora primária (PCS). No entanto, o esforço cirúrgico máximo para atingir doença residual mínima (RD ≤10mm ou idealmente RD0) foi crucial, associando-se a melhores resultados de sobrevida e sublinhando a importância da qualidade da citorredução para esses pacientes.
🇧🇷 traduzidoPublicações recentes
Endometrial pathology and surgical extent in ovarian adult granulosa cell tumor: associations with stage and survival.
Multiplexed Imaging Mass Cytometry Reveals Tumor-immune Microenvironment-dependent Hormone Receptor Expression in Adult-Type Ovarian Granulosa Cell Tumors.
The role of neoadjuvant chemotherapy in advanced-stage clear cell ovarian cancer: A GCIG multi-institutional retrospective cohort study.
Loss of SMARCA4 Leads to Intron Retention and Generation of Tumor-Associated Antigens in Small Cell Carcinoma of the Ovary, Hypercalcemic Type.
Targeting Mediator Kinase Cyclin-Dependent Kinases 8/19 Potentiates Chemotherapeutic Responses, Reverses Tumor Growth, and Prolongs Survival from Ovarian Clear Cell Carcinoma.
📚 EuropePMC8 artigos no totalmostrando 41
Endometrial pathology and surgical extent in ovarian adult granulosa cell tumor: associations with stage and survival.
American journal of obstetrics and gynecologyExperiences of radiotherapy for treatment of Granulosa Cell Tumor of the ovary: insights from the GCT-survivor sisters.
Gynecologic oncologyMultiplexed Imaging Mass Cytometry Reveals Tumor-immune Microenvironment-dependent Hormone Receptor Expression in Adult-Type Ovarian Granulosa Cell Tumors.
Cancer research communicationsThe role of neoadjuvant chemotherapy in advanced-stage clear cell ovarian cancer: A GCIG multi-institutional retrospective cohort study.
Gynecologic oncologyLoss of SMARCA4 Leads to Intron Retention and Generation of Tumor-Associated Antigens in Small Cell Carcinoma of the Ovary, Hypercalcemic Type.
Cancer researchTargeting Mediator Kinase Cyclin-Dependent Kinases 8/19 Potentiates Chemotherapeutic Responses, Reverses Tumor Growth, and Prolongs Survival from Ovarian Clear Cell Carcinoma.
CancersPrimary versus interval cytoreductive surgery in patients with rare epithelial or non-epithelial ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer SocietySuper-enhancers and efficacy of triptolide in small cell carcinoma of the ovary hypercalcemic type.
iScienceCRISPR targeting of FOXL2 c.402C>G mutation reduces malignant phenotype in granulosa tumor cells and identifies anti-tumoral compounds.
Molecular oncologyGW0742 as a Potential TRα and TRβ Antagonist Reduces the Viability and Metabolic Activity of an Adult Granulosa Tumour Cell Line and Simultaneously Upregulates TRβ Expression.
CancersEpigenetic Therapy in a Rare Ovarian Cancer - A Double-Edged Sword.
The New England journal of medicineSingle-molecule epiallelic profiling of DNA derived from routinely collected Pap specimens for noninvasive detection of ovarian cancer.
Clinical and translational medicinePeritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC).
Pleura and peritoneumA phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial.
International journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyMucinous ovarian carcinoma: A survey of practice in Australia and New Zealand.
The Australian & New Zealand journal of obstetrics & gynaecologySuccessful treatment of stage IVB ovarian carcinosarcoma with PARP Inhibitor: A case report.
Gynecologic oncology reportsInfiltrative pattern of invasion is independently associated with shorter survival and desmoplastic stroma markers FAP and THBS2 in mucinous ovarian carcinoma.
HistopathologyTop advances of the year: Ovarian cancer.
CancerImpact of surgery and chemotherapy in ovarian sex cord-stromal tumors from the multicentric Salomé study including 469 patients. A TMRG and GINECO group study.
Gynecologic oncologyWhole exome sequencing of low grade serous ovarian carcinoma identifies genomic events associated with clinical outcome.
Gynecologic oncologyHow social media can help to understand treatment experiences of survivors of rare cancers: Findings from the Granulosa Cell Tumor Survivor Sisters Facebook group member survey.
CancerA Rare Case of Ruptured Malignant Ovarian Brenner Tumor.
The American journal of case reportsRare Histologies and Infrequent Indications for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Anticancer researchRare Ovarian Cancer's First Positive Trial.
Cancer discoveryNon-Gestational Ovarian Choriocarcinoma: A Rare Ovarian Cancer Subtype.
Diagnostics (Basel, Switzerland)Standardizing HIPEC and perioperative care for patients with ovarian cancer in the Netherlands using a Delphi-based consensus.
Gynecologic oncology reportsDNA Methylation Profiles of Ovarian Clear Cell Carcinoma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive OncologyLow-Grade Ovarian Serous Adenocarcinoma with Lymph Node Metastasis in Neck.
Diagnostics (Basel, Switzerland)Immunotherapy in rare ovarian cancer.
Current opinion in oncologyFamilial Occurrence of Adult Granulosa Cell Tumors: Analysis of Whole-Genome Germline Variants.
CancersMalignant struma ovarii: surgical, histopathological and survival outcomes for thyroid-type carcinoma of struma ovarii with recommendations for standardising multi-modal management. A retrospective case series sharing the experience of a single institution over 10 years.
Archives of gynecology and obstetricsConfronting a rare ovarian cancer during lockdown.
The Lancet. Respiratory medicineMEK Inhibitors for the Treatment of Low-Grade Serous Ovarian Cancer: Expanding Therapeutic Options for a Rare Ovarian Cancer Subtype.
Journal of clinical oncology : official journal of the American Society of Clinical OncologyNatural killer cell impairment in ovarian clear cell carcinoma.
Journal of leukocyte biologyArginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase-Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic Type.
Clinical cancer research : an official journal of the American Association for Cancer ResearchLow-grade serous ovarian cancer: State of the science.
Gynecologic oncologyManagement of Rare Ovarian Cancer Histologies.
Journal of clinical oncology : official journal of the American Society of Clinical OncologyMetastasis of ovarian cancer to the bile duct: a case report.
Surgical case reportsOvarian Clear Cell Carcinoma in Cowden Syndrome.
Journal of the National Comprehensive Cancer Network : JNCCNIdentification of Driver Mutations in Rare Cancers: The Role of SMARCA4 in Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT).
Methods in molecular biology (Clifton, N.J.)Involvement of Chromatin Remodeling Genes and the Rho GTPases RhoB and CDC42 in Ovarian Clear Cell Carcinoma.
Frontiers in oncologyAssociações
Organizações que acompanham esta doença — pra ter apoio e orientação
Ainda não temos associações cadastradas para Câncer de ovário raro.
É de uma associação que acompanha esta doença? Fale com a gente →
Comunidades
Grupos ativos de quem convive com esta doença aqui no Raras
Ainda não existe comunidade no Raras para Câncer de ovário raro
Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.
Tire suas dúvidas
Perguntas, dicas e experiências compartilhadas aqui na página
Participe da discussão
Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.
Fazer loginDoenças relacionadas
Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico
Referências e fontes
Bases de dados externas citadas neste artigo
Publicações científicas
Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.
- Endometrial pathology and surgical extent in ovarian adult granulosa cell tumor: associations with stage and survival.
- Super-enhancers and efficacy of triptolide in small cell carcinoma of the ovary hypercalcemic type.
- Experiences of radiotherapy for treatment of Granulosa Cell Tumor of the ovary: insights from the GCT-survivor sisters.
- Multiplexed Imaging Mass Cytometry Reveals Tumor-immune Microenvironment-dependent Hormone Receptor Expression in Adult-Type Ovarian Granulosa Cell Tumors.
- The role of neoadjuvant chemotherapy in advanced-stage clear cell ovarian cancer: A GCIG multi-institutional retrospective cohort study.
- Loss of SMARCA4 Leads to Intron Retention and Generation of Tumor-Associated Antigens in Small Cell Carcinoma of the Ovary, Hypercalcemic Type.
- Targeting Mediator Kinase Cyclin-Dependent Kinases 8/19 Potentiates Chemotherapeutic Responses, Reverses Tumor Growth, and Prolongs Survival from Ovarian Clear Cell Carcinoma.
Bases de dados e fontes oficiais
Identificadores e referências canônicas usadas para montar este verbete.
- ORPHA:213500(Orphanet)
- OMIM OMIM:167000(OMIM)
- MONDO:0008170(MONDO)
- GARD:7295(GARD (NIH))
- Variantes catalogadas(ClinVar)
- Busca completa no PubMed(PubMed)
- Artigo Wikipedia(Wikipedia)
- Q172341(Wikidata)
Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.
Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar
